Efficacy and Safety Study of Stemchymal® in Polyglutamine Spinocerebellar Ataxia

Summary

The purpose of the clinical trial is to study the therapeutic efficacy and safety of Stemchymal® infusions for polyglutamine spinocerebellar ataxia treatment by a randomized, double-blind, placebo-controlled study design. Eligible subjects will receive Stemchymal® through intravenous infusion.

Timeline

Start

2015-09

Primary completion

2021-02-26

Completion

2021-02-26

Drugs

Indications